MeOmics capitalizes on recent advances in genetics and stem cell technology, combining genomics, phenomics and cellomics to create a unique Precision Psychiatry platform.
The MeOmics platform, combining unique neuronal cell assays, data-rich descriptors of each individual and background genetics, brings the complexity of population level clinical trails to preclinical screening, prior to clinical trial expense.
The MeOmics platform further brings the promise of personalized medicine to psychiatry, through the use of individual patient derived neurons for optimal treatment selection.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Cardiff, Gb
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.meomics.tech
- Keywords
- | SaaS | Tech | Ecommerce.
- HQ
- Cardiff
Meomics Precision Medicine Ltd Questions
Meomics Precision Medicine Ltd's website is http://www.meomics.tech
Meomics Precision Medicine Ltd's LinkedIn profile is https://uk.linkedin.com/company/meomics-technology
Meomics Precision Medicine Ltd has
8 employees.
View email and phone details for 8
employees at Meomics Precision Medicine Ltd.
Meomics Precision Medicine Ltd's industry is
Pharmaceutical Manufacturing
Meomics Precision Medicine Ltd's top competitors are
Oncoflow,
Mendea Technologies,
Blue Sky Pharmaceuticals Ltd,
Ealtra,
Biomorphix,
Swiftr Bioscience- A Crispr Diagnostics Company,
Enoda Health,
Biomarx Ltd.,
Neem Biotech Limited,
Mariposa Therapeutics.
Meomics Precision Medicine Ltd's categories are Pharmaceutical Manufacturing
Meomics Precision Medicine Ltd's founding year is 2021
